Newsroom - Imagene

Newsroom

The Power of AI

Revolutionizing & Democratizing Cancer Diagnosis

Interviewed by Bryan Walsh, Editor Future Perfect, Vox.

Imagene taps Oracle Cloud Infrastructure in fight against cancer

Oracle Connect | 3 October, 2024

Medtech startup brings Oracle AI to bear on cancer drug research

Computer Weekly | 23 September, 2024

Imagene and Oracle unveil Artificial Intelligence model for cancer

CTECH | 10 September, 2024

Discover the Top 20 Promising Global Precision Medicine Startups

StartUs | 9 January, 2024

Beyond OpenAI: 7 promising startups that have saved lives, sped up drug development and improved manufacturing

Market Watch | 1 June, 2023

Imagene Profiles Cancer Biomarkers in Real Time

Med Gadget | 22 March, 2023

Press Releases

Imagene Laboratory Receives Accreditation From College of American Pathologists

27 March, 2025

Imagene Announces a Collaboration with Tempus to Advance AI-Driven Diagnostics for Non-Small Cell Lung Cancer

5 February, 2025

Imagene Partners with Oracle to Launch CanvOI on Oracle Cloud Infrastructure

10 September, 2024

Imagene Advances LungOI Commercialization With New Payment Code and Pricing, Complementing Its Prior CLIA Certified US Lab

28 May, 2024

Imagene Increases Accessibility of Rapid AI-Based Biomarker Profiling Through Integration With Sectra

12 February, 2024

Imagene Announces LungOI, the First AI-Based NSCLC Molecular Panel for Immediate Cancer Biomarker Profiling

6 September, 2023

Hoag Hospital and Imagene Partner to Empower Rapid Cancer Diagnosis for Personalized Cancer Care

15 August, 2023

Imagene Launches ImageneOI Platform on Oracle Cloud Infrastructure to Democratize AI-Based Molecular Profiling in Oncology

11 August, 2023

Imagene’s AI-Based Molecular Profiling Revolutionizes Lung Cancer Diagnostics: Two Patients Receive Immediate Targeted Therapy, Avert Brain Radiation

26 July, 2023

Imagene Welcomes World-Leading Oncologists at the Forefront of Precision Oncology to Its Scientific Advisory Board

31 July, 2023

Imagene taps Oracle Cloud Infrastructure in fight against cancer

Oracle Connect | 3 October, 2024

Medtech startup brings Oracle AI to bear on cancer drug research

Computer Weekly | 23 September, 2024

Imagene and Oracle unveil Artificial Intelligence model for cancer

CTECH | 10 September, 2024

Discover the Top 20 Promising Global Precision Medicine Startups

StartUs | 9 January, 2024

Beyond OpenAI: 7 promising startups that have saved lives, sped up drug development and improved manufacturing

Market Watch | 1 June, 2023

Imagene Profiles Cancer Biomarkers in Real Time

Med Gadget | 22 March, 2023

The Cancer Diagnosis Paradox

FORBES | 10 March, 2023

AI Cuts Cancer Wait From Weeks to Minutes

No Camels | 22 January, 2023

250 most promising early-stage Digital Health ventures

Galen Growth | 14 December, 2022

New AI Technology Detects Cancer Mutations in Minutes

The Epoch Times | 15 November, 2022

Imagene Laboratory Receives Accreditation From College of American Pathologists

27 March, 2025

Imagene Announces a Collaboration with Tempus to Advance AI-Driven Diagnostics for Non-Small Cell Lung Cancer

5 February, 2025

Imagene Partners with Oracle to Launch CanvOI on Oracle Cloud Infrastructure

10 September, 2024

Imagene Advances LungOI Commercialization With New Payment Code and Pricing, Complementing Its Prior CLIA Certified US Lab

28 May, 2024

Imagene Increases Accessibility of Rapid AI-Based Biomarker Profiling Through Integration With Sectra

12 February, 2024

Imagene Announces LungOI, the First AI-Based NSCLC Molecular Panel for Immediate Cancer Biomarker Profiling

6 September, 2023

Hoag Hospital and Imagene Partner to Empower Rapid Cancer Diagnosis for Personalized Cancer Care

15 August, 2023

Imagene Launches ImageneOI Platform on Oracle Cloud Infrastructure to Democratize AI-Based Molecular Profiling in Oncology

11 August, 2023

Imagene’s AI-Based Molecular Profiling Revolutionizes Lung Cancer Diagnostics: Two Patients Receive Immediate Targeted Therapy, Avert Brain Radiation

26 July, 2023

Imagene Welcomes World-Leading Oncologists at the Forefront of Precision Oncology to Its Scientific Advisory Board

31 July, 2023